| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $73.4M | — | -14.1% |
| R&D Expense | $1.8M | — | -70.2% |
| SG&A Expense | $15.2M | — | -4.9% |
| Operating Income | -$4.8M | — | -149.4% |
| Pre-tax Income | -$11.3M | — | -67.4% |
| Income Tax | -$5.7M | — | +29.0% |
| Net Income | -$5.6M | — | -535.6% |
| EPS (Basic) | -$0.09 | — | -800.0% |
| EPS (Diluted) | -$0.09 | — | -800.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $133.2M | +445.9% | +232.4% |
| Accounts Receivable | $42.6M | -31.0% | +38.5% |
| Current Assets | $213.4M | +73.9% | +83.4% |
| Total Assets | $1.06B | +10.5% | +19.9% |
| Current Liabilities | $97.1M | -6.9% | -4.5% |
| Long-term Debt | $456.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $12.9M | — | -56.5% |
| Capital Expenditures | $24.4M | — | +110.7% |
| Investing Cash Flow | -$19.4M | — | -108.9% |
| Financing Cash Flow | $115.1M | — | +2532.9% |
| Free Cash Flow | -$11.5M | — | -163.2% |
| +48.7% |
| Total Liabilities | $548.7M | +18.8% | +30.5% |
| Stockholders' Equity | $8.2M | +163.6% | -85.6% |